Comparison of Insulin Glargine Versus Biphasic Insulin Aspart 30/70 or Biphasic Insulin Aspart 30/70 in Combination With Metformin in Subjects With Type 2 Diabetes.
Status and phase
Completed
Phase 4
Conditions
Diabetes
Diabetes Mellitus, Type 2
Treatments
Drug: biphasic insulin aspart
Drug: metformin
Drug: insulin glargine
Details and patient eligibility
About
This trial is conducted in Asia. The aim of the trial is to compare the glycaemic control of Insulin glargine versus Biphasic Insulin Aspart 30/70 or Biphasic Insulin Aspart 30/70 in combination with metformin in subjects with Type 2 Diabetes.
Enrollment
97 patients
Sex
All
Ages
35+ years old
Volunteers
No Healthy Volunteers
Inclusion criteria
- Type 2 diabetes
- Body mass index equal to or lesser than 35.0 kg/m2
- Currently treated with oral hypoglycaemic drug
Exclusion criteria
- Known hypoglycaemia unawareness or recurrent major hypoglycaemia as judged by the Investigator
- Any condition that the Investigator and/or the Sponsor feel would interfere with trial participation or evaluation of results
Trial design
Primary purpose
Treatment
Allocation
Randomized
Interventional model
Parallel Assignment
Masking
None (Open label)
Trial contacts and locations
1
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal
© Copyright 2026 Veeva Systems